文献速递冠心病血脂与心血管预防

南亚人群冠状动脉疾病全基因组多基因评分验证

Validation of a Genome-Wide Polygenic Score for Coronary Artery Disease in South Asians.
PubMed 文献 · J Am Coll Cardiol · 2020-01-01

研究利用既往全基因组关联研究汇总统计量构建南亚人群冠状动脉疾病多基因评分(GPSCAD),并在英国生物银行南亚裔、孟加拉国病例对照及印度新招募人群中验证。结果显示GPSCAD与冠心病风险显著相关,高评分者风险显著升高,为 ancestry-specific 多基因评分评估提供可推广框架。

要点

  • GPSCAD含6,630,150个常见DNA变异,每标准差OR在英国生物银行南亚裔为1.58、孟加拉国为1.60、印度为1.66(均p<0.001)。
  • 与中间五分位相比,GPSCAD前5%者冠心病风险显著升高,OR在英国生物银行南亚裔、孟加拉国、印度研究中分别为4.16、2.46、3.22(均p<0.05)。
  • 该GPSCAD在南亚三个独立研究中验证,支持 ancestry-specific 多基因评分用于高危个体识别。

核心结论

  • 新构建的南亚人群GPSCAD在三个独立南亚研究中与冠心病风险显著相关,并提供可推广的 ancestry-specific 多基因评分评估框架。

研究设计与样本

  • 利用既往全基因组关联研究汇总统计量推导南亚人群GPSCAD,在英国生物银行7,244名南亚裔参与者中验证,并在孟加拉国491例病例对照研究中测试。
  • 利用1,522名印度个体全基因组测序构建静态 ancestry 和GPSCAD参考分布,并在印度新招募的1,800例冠心病病例和1,163名对照中测试投射框架。

主要发现

  • GPSCAD含6,630,150个常见DNA变异,每标准差OR在英国生物银行南亚裔为1.58、孟加拉国研究为1.60(均p<0.001)。
  • 印度病例对照研究个体投射到静态参考分布后,每标准差OR为1.66(p<0.001)。
  • 与中间五分位相比,GPSCAD前5%者冠心病风险最高,OR在英国生物银行南亚裔、孟加拉国、印度研究中分别为4.16、2.46、3.22(均p<0.05)。

临床怎么用

  • 该GPSCAD可用于南亚人群冠心病高危个体识别,尤其关注评分前5%者。
  • 采用静态 ancestry 和GPSCAD参考分布投射框架,支持在南亚人群中开展 ancestry-specific 多基因评分评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Genome-wide polygenic scores (GPS) integrate information from many common DNA variants into a single number. Because rates of coronary artery disease (CAD) are substantially higher among South Asians, a GPS to identify high-risk individuals may be particularly useful in this population. OBJECTIVES: This analysis used summary statistics from a prior genome-wide association study to derive a new GPSCAD for South Asians. METHODS: This GPSCAD was validated in 7,244 South Asian UK Biobank participants and tested in 491 individuals from a case-control study in Bangladesh. Next, a static ancestry and GPSCAD reference distribution was built using whole-genome sequencing from 1,522 Indian individuals, and a framework was tested for projecting individuals onto this static ancestry and GPSCAD reference distribution using 1,800 CAD cases and 1,163 control subjects newly recruited in India. RESULTS: The GPSCAD, containing 6,630,150 common DNA variants, had an odds ratio (OR) per SD of 1.58 in South Asian UK Biobank participants and 1.60 in the Bangladeshi study (p < 0.001 for each). Next, individuals of the Indian case-control study were projected onto static reference distributions, observing an OR/SD of 1.66 (p < 0.001). Compared with the middle quintile, risk for CAD was most pronounced for those in the top 5% of the GPSCAD distribution-ORs of 4.16, 2.46, and 3.22 in the South Asian UK Biobank, Bangladeshi, and Indian studies, respectively (p < 0.05 for each). CONCLUSIONS: The new GPSCAD has been developed and tested using 3 distinct South Asian studies, and provides a generalizable framework for ancestry-specific GPS assessment.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Wang M, Menon R, Mishra S, et al. Validation of a Genome-Wide Polygenic Score for Coronary Artery Disease in South Asians. J Am Coll Cardiol. 2020. PMID: 32762905. doi:10.1016/j.jacc.2020.06.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。